The EST Hub invites applications for funding to support the development of projects that advance understanding of ethical implications or societal impacts of science and technology innovation.
This grant is to attract and increase junior faculty members, including highly qualified physicians, physician-scientists, population-based or basic/translational scientists, and to maximize their potential to be leaders in academic medicine
The Beckman Center for Molecular and Genetic Medicine announces this year’s call for proposals. 2-year grants of $200,000 ($100,000/year) for technology development in the biomedical sciences.
Two $30,000 grants to immerse early-career graduate students into modern proteomic mass spectrometry methods. This personalized training will empower student researchers with skills that will boost their research careers at Stanford and beyond.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2021 Pilot and Feasibility (P&F) Program led by Dr. Fredric Kraemer.
The Stanford CCNE-TD, an NCI funded Phase-III U54 grant, is soliciting proposals for Developmental Projects of Cancer Nanotechnology research. Up to 5 awards, and each award will receive one year funding of up to $50,000.
Grants of up to $5,000 to support new mass spectrometry projects and methodologies in emerging research areas, early phase investigations, and pilot studies.
The IMA, CDCM and CCT, seek to accelerate the development of promising and innovative early-stage translational stem cell and gene therapies that fill unmet clinical needs.
We invite Stanford researchers across all disciplines to submit interdisciplinary research proposals on learning differences and/or the future of special education for projects funded up to $80,000 for a one year project.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
